BG
GSK icon

Bollard Group’s GSK GSK Stock Holding History

Bollard Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-153
Closed -$5K – 506
2023
Q2 		$5K Buy
+153
New +$5.49K ﹤0.01% 390
2019
Q3 		– Sell
-43,807
Closed -$2.19M – 242
2019
Q2 		$2.19M Buy
43,807
+620
+1% +$31.1K 0.08% 110
2019
Q1 		$2.26M Buy
43,187
+522
+1% +$26.1K 0.09% 106
2018
Q4 		$2.04M Buy
42,665
+127
+0.3% +$6.25K 0.09% 99
2018
Q3 		$2.14M Buy
42,538
+121
+0.3% +$6.15K 0.09% 103
2018
Q2 		$2.14M Buy
42,417
+158
+0.4% +$7.96K 0.1% 99
2018
Q1 		$2.06M Buy
+42,259
New +$1.97M 0.1% 104
2017
Q4 		– Sell
-41,162
Closed -$2.09M – 259
2017
Q3 		$2.09M Buy
41,162
+462
+1% +$23.4K 0.11% 103
2017
Q2 		$2.19M Buy
40,700
+542
+1% +$28.9K 0.12% 102
2017
Q1 		$2.12M Buy
40,158
+465
+1% +$23.6K 0.12% 101
2016
Q4 		$1.91M Buy
39,693
+430
+1% +$21.2K 0.12% 103
2016
Q3 		$2.12M Buy
39,263
+277
+0.7% +$15.2K 0.14% 92
2016
Q2 		$2.11M Buy
38,986
+14,888
+62% +$784K 0.14% 84
2016
Q1 		$1.22M Buy
24,098
+325
+1% +$16.2K 0.1% 115
2015
Q4 		$1.2M Buy
23,773
+343
+1% +$17.5K 0.1% 115
2015
Q3 		$1.13M Buy
23,430
+4,184
+22% +$218K 0.09% 129
2015
Q2 		$1M Buy
19,246
+126
+0.7% +$7.09K 0.08% 140
2015
Q1 		$1.1M Buy
19,120
+10,400
+119% +$596K 0.08% 129
2014
Q4 		$466K Buy
+8,720
New +$488K 0.04% 158

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bollard Group's GSK Position: Q3 2023 in Review

Bollard Group sold out of GSK (GSK) in Q3 2023, closing a stake of 153 shares — an estimated $5K sold.

Bollard Group first reported a position in GSK in Q4 2014 and held it in 19 quarters. The position peaked at $2.26M in Q1 2019. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Bollard Group reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
  • Bollard Group sold 153 GSK shares in Q3 2023, an estimated $5K.
  • Bollard Group first reported a position in GSK in Q4 2014 and held it in 19 quarters.
  • Bollard Group's GSK position peaked at $2.26M in Q1 2019.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.